TransEnterix competitors

I am the Chief Executive Officer, President and Chairman of Abiomed, Inc. (NASDAQ: ABMD), the only medical device company focused solely on heart recovery. At Abiomed, we are driven by our four principles: recovering hearts and saving lives, leading in technology and innovation, growing shareholder value and sustaining a winning culture of putting patients first. As a U.S. military veteran, I also serve as Co-Founder and Chairman of the Mentoring Veterans Program (MVPvets), a nonprofit organization committed to helping military veterans network with industry mentors to discover career opportunities in the life sciences industry.

Gary Guthart joined Intuitive Surgical in April 1996. Effective January 2010, Guthart was appointed as Chief Executive Officer. In July 2007, he was promoted to President. Prior to that, in February 2006, Guthart assumed the role of Chief Operating Officer. Prior to joining Intuitive, Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formerly Stanford Research Institute). Guthart is currently a member of the Board of Directors of Affymetrix, Inc. He received a B.S. in Engineering from the University of California, Berkeley and an M.S. and a Ph.D. in Engineering Science from the California Institute of Technology.

Said Hilal is a Board Member at Applied Medical and President/CEO at Applied Medical. He attended California State University Long Beach and University of Southern California.

Gary Burbach is a Chief Executive Officer at Thoratec and is based in Pleasanton, California.

Mr. Wypych joined Cardiac Dimensions, Inc. in 2003 with more than 10 years of financial and strategic management experience in the financial and life sciences industries. Prior to joining Cardiac Dimensions, Mr. Wypych served as Director of Finance and Administration at Spinal Dynamics Corporation, an early-stage artificial inter-vertebral disc company. At Spinal Dynamics, he was responsible for finance and accounting, human resources, and administration. During his tenure at Spinal Dynamics, Mr. Wypych was instrumental in developing the initial revenues of the company, the financing of operations and eventual sale of the company to Medtronic, Inc. Before joining Spinal Dynamics, Mr. Wypych served as a Senior Audit Manager for KPMG LLP managing several financial audit engagements, mergers and acquisitions projects and SEC registrations. Mr. Wypych holds a Bachelor of Arts degree in Business Administration from Seattle University and is a licensed Certified Public Accountant in the State of Washington.

Nicholas T. Curtis began his career in ophthalmology almost 30 years ago. Beginning as a founding member of the ophthalmic subsidiary of Chiron Corporation, Nick has had increasing responsibilities in sales, marketing and senior management roles participating in many of the major trends in ophthalmology including: the evolution of anterior to posterior segment IOLs; cataract surgery procedures from intracapsular to extracapsular and phacoemulsification to femtosecond; and refractive surgery from RK, and ALK to LASIK. In 1996, Mr. Curtis founded Refractive Surgical Resources, a Company that pioneered transportable surgical services and was acquired by Laser Vision Centers, Inc. in 1998. Mr. Curtis also served as the Senior Vice President of Sales and Marketing for STAAR Surgical Company and was the Chief Commercial Officer at WaveTec Vision just prior to joining LENSAR.

King Nelson joined Q'Apel Medical as CEO and Director in 2019.King Nelson has more than 30 years of diverse experience and expertise with medical devices. Previously, he served as president and CEO of Kerberos Proximal Solutions, which was acquired by FoxHollow, and as president and CEO of VenPro, which was acquired by Medtronic. Prior to that, he spent 19 years with Baxter and American Hospital Supply Corporation with roles that included division president for Dade Diagnostics, Bentley Labs and Baxter’s Perfusion Services. He currently serves on the board of directors for several early stage private medical device companies. King received his Bachelor’s degree from Texas Tech University and MBA from the University of Miami.